Concepedia

Author

Nancy Chan

Rutgers, The State University of New JerseyORCID

Also Known As

Cecilia Castillo, D 82a Chamberlain, Harding, James J, N Chan, N G Chan, N. Chan, N.g Chan, NANCY CHAN, Nancy Chan, Nancy G Chan

115

Publications

2K

Citations

20

H-Index

81

Concepts

All Affiliations

Rutgers, The State University of New JerseyRutgers Cancer InstituteDana-Farber Cancer InstituteLondon Health Sciences CentreLawson Health Research Institute
NC

About

Nancy Chan is an author at Rutgers, The State University of New Jersey specializing in medicine, radiation oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

286

2

Health Sciences

4

4

81

3

Engineering

1

1

20

4

Public Health

1

1

29

5

Social Sciences

1

1

20

Nancy Chan

×

31

Publications

1.8K

Citations

20

H-Index

YearCitations

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

Matteo Palmeri, Janice M. Mehnert, Ann W. Silk,

ESMO Open

2021

333

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors

Rastislav Bahleda, Antoîne Italiano, Cinta Hierro,

Clinical Cancer Research

2019

237

Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

Nancy Chan, Amy D. Willis, Naomi Kornhauser,

Clinical Cancer Research

2016

216

Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer

Anshuman Panda, Janice M. Mehnert, Kim M. Hirshfield,

JNCI Journal of the National Cancer Institute

2017

213

First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors

Mark N. Stein, Joseph R. Bertino, Howard L. Kaufman,

Clinical Cancer Research

2017

153

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

CH Barcenas, Sara A. Hurvitz, Jack A. Di Palma,

Annals of Oncology

2020

102

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

Mark N. Stein, Jyoti Malhotra, Rohinton S. Tarapore,

Journal for ImmunoTherapy of Cancer

2019

70

Implications of failure to achieve a result from prenatal maternal serum cell‐free <scp>DNA</scp> testing: a historical cohort study

Nancy Chan, M‐E Smet, Rhiannon Sandow,

BJOG An International Journal of Obstetrics & Gynaecology

2017

52

Inference of Germline Mutational Status and Evaluation of Loss of Heterozygosity in High-Depth, Tumor-Only Sequencing Data

Hossein Khiabanian, Kim M. Hirshfield, Mendel Goldfinger,

JCO Precision Oncology

2018

31

Cytokines in umbilical cord blood and the impact of labor events in low-risk term pregnancies

Cynthia Chan, Kelly L. Summers, Nancy Chan,

Early Human Development

2013

29

Page 1